4 IBD 50 Stocks Poised To Bounce Back With Market

As the market bounces back after five straight sessions of losses, here's a look at five IBD 50 stocks that could bounce back after finding support at their moving averages: United Therapeutics, Ellie Mae, Epam Systems and Illumina. United Therapeutics staged a huge upside reversal on Tuesday, falling nearly 8% before moving to higher ground as it found support at its 200-day line. The biotech is working on a price consolidation with a 190.39 buy point. Ellie Mae fell as much as 5% intraday, but trimmed much of those losses by the afternoon as it found support at the 50-day line. The financial software firm's stock is currently trading about 7% below its July 20 high. Epam Systems is trading near its 50-day line for a second session, testing support at that level. The IT outsourcing company is back in buy range from a price consolidation with a 70.59 buy point, which it initially cleared in late May. And Illumina has been hugging its 50-day line for several sessions after it gapped down on a Q2 revenue miss. The maker of gene sequencing systems is trading 9% off of its high.